The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Grezina L.A.

GBUZ «Jamalo-Nenetskij okruzhnoj Tsentr po profilaktike i bor'be so SPID», kandidat meditsinskih nauk

Dement'eva N.E.

Laboratorija Sankt-Peterburgskogo Tsentra SPID

Zajtseva N.N.

Privolzhskij okruzhnoj tsentr po profilaktike i bor'be so SPID FBUN NNIIEM im. akad. I.N. Blohinoj

Kazennova E.V.

FGBU «FNITsEM im. N.F. Gamalei» Minzdrava Rossii

Kireev D.E.

FBUN «Tsentral'nyj nauchno-issledovatel'skij institut epidemiologii» Rospotrebnadzora

Shemshura A.B.

GBUZ «Klinicheskij tsentr profilaktiki i bor'by so SPID» MZ Krasnodarskogo kraja

Analysis of HIV drug resistance

Authors:

Grezina L.A., Dement'eva N.E., Zajtseva N.N., Kazennova E.V., Kireev D.E., Shemshura A.B.

More about the authors

Journal: Laboratory Service. 2017;6(3): 217‑237

Read: 6056 times


To cite this article:

Grezina LA, Dement'eva NE, Zajtseva NN, Kazennova EV, Kireev DE, Shemshura AB. Analysis of HIV drug resistance. Laboratory Service. 2017;6(3):217‑237. (In Russ.)
https://doi.org/10.17116/labs201763217-237

References:

  1. Bobkova MR. Lekarstvennaya ustoichivost' VICh. Moskva: Chelovek; 2014. (In Russ.)
  2. VICh-infektsiya i SPID. Natsional'noe rukovodstvo ed. by VV Pokrovskii. Moskva: Geotar-Media; 2013. (In Russ.)
  3. Instruktsiya po primeneniyu nabora reagentov dlya opredeleniya tropizma i vyyavleniya mutatsii ustoichivosti VICh-1 «AmpliSens HIV-Resist-Seq». 2012. (In Russ.) http://www.interlabservice.ru/upload/iblock/d96/hiv_resist_seq-_zaregistr_la_280316.pdf
  4. Metodicheskie rekomendatsii po analizu i interpretatsii rezul'tatov issledovaniya, provedennogo s ispol'zovaniem nabora reagentov dlya opredeleniya tropizma i vyyavleniya mutatsii ustoichivosti virusa immunodefitsita cheloveka (VICh-1) k antiretrovirusnym preparatam v klinicheskom materiale metodom polimeraznoi tsepnoi reaktsii (PTsR) s posleduyushchim sekvenirovaniem produktov amplifikatsii «amplisens HIV-Resist-seq» AmpliSens. 2016. (In Russ.) http://www.interlabservice.ru/upload/iblock/6ea/hiv_resist-seq-_metodich.-rekomendatsii_la_280316.pdf
  5. Molekulyarno-biologicheskoe issledovanie «Opredelenie kontsentratsii RNK VICh v plazme krovi». Klinicheskie rekomendatsii. (In Russ.) http://www.fedlab.ru/upload/medialibrary/7d0/kochetov-ag.-klin-rek_-kld.-molekulyarno_biologicheskoe-issledovanie-_opredelenie-kontsentratsii-rnk-vich-v-plazme-krovi_-2014.pdf
  6. Organizatsiya raboty laboratorii, ispol'zuyushchikh metody amplifikatsii nukleinovykh kislot pri rabote s materialom, soderzhashchim mikroorganizmy I—IV grupp patogennosti. Metodicheskie ukazaniya MU 1.3.2569-09. 2009. (In Russ.) http://mibio.ru/docs/110/mu_1.3.2569-09_amplifikatsii_nukleinovih_kislot_pri_rabote_s_materialom.pdf
  7. Pokrovskii V, Yurin O, Kravchenko A., et al. Natsional'nye rekomendatsii po dispansernomu nablyudeniyu i lecheniyu bol'nykh VICh-infektsiei. Epidemiologiya i infektsionnye bolezni. Aktual'nye voprosy. 2016;6(prilozhenie). (In Russ.)
  8. Bertagnolio S, Derdelinckx I, Parker M, et al. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy Antivir Ther. 2008;Suppl.2:49-57. Available at: http://www.who.int/hiv/pub/drugresistance/hiv_reslab_strategy.pdf?ua=1
  9. BHIVA guidelines on the routine investigation and monitoring of HIV-1-positive adults 2016. Available at: http://www.bhiva.org/documents/Guidelines/Monitoring/2016-BHIVA-Monitoring-Guidelines.pdf
  10. Ebbert MT, Mallory MA, Wilson AR, et al. Application of a new informatics tool for contamination screening in the HIV sequencing laboratory. J Clin Virol. 2013;57(3):249-253.
  11. European AIDS Clinical Society (EACS), Guidelines, Version 8.0. 2015. Available at: http://www.eacsociety.org/files/guidelines_8.1-english.pdf
  12. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of health and human services. 2016. Available at: http://aidsinfo.nih.gov/guidelines
  13. HIV drug resistance laboratory training package. 2009. Available at: http://www.who.int/hiv/pub/drugresistance/lab_training/en/
  14. HIV 2015/16. Под ред. Hoffmann C, Rockstroh J. Available at: https://hivbook.files.wordpress.com/2016/04/hiv-2015-16-complete.pdf
  15. Hofstra LM, Sauvageot N, Albert J, et al. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe. Clin Infect Dis. 2016;62(5):655-663.
  16. Vandamme AM, Camacho RJ, Ceccherini-Silberstein F, et al. European recommendations for the clinical use of HIV drug resistance testing: 2011 update. AIDS Rev. 2011;13(2):77-108.
  17. Vandekerckhove LP, Wensing AM, Kaiser R, et al. European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis. 2011;11(5):394-407.
  18. ViroSeq HIV-1 Genotyping System. Инструкция для пользователей. 2011.
  19. WHO/HIVResNet HIV drug resistance laboratory strategy. 2010. Available at: http://www.who.int/hiv/pub/drugresistance/hiv_reslab_strategy.pdf

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.